Spark Therapeutics adds COO to management team
Mr. Furey has 25 years of experience in developing and implementing operational strategies and leading commercial and technical teams.
Prior to joining Spark Therapeutics, Mr. Furey was senior vice president and head of global operations for Baxalta, where he directed manufacturing, quality, engineering, and process development.
He led the team that coordinated and delivered the successful establishment of Baxalta through a spin out from Baxter and led the Baxter Vaccine inline business.
Mr. Furey also spent two years in China as general manager of Pfizer's vaccine business unit following a role with responsibility for global pricing and reimbursement at Pfizer Vaccines.
Earlier in his career, he held both commercial and operations positions of increasing scope and responsibility with Pfizer and Wyeth Pharmaceuticals.
Mr. Furey has an executive M.B.A. from St. Joseph's University, Philadelphia , a B.S. from Trinity College, Dublin, and a diploma in Environmental Health from the Dublin Institute of Technology. ■
LATEST MOVES FROM Pennsylvania
- Penn Virginia appoints Benjamin A. Mathis as vice president
- AMETEK names Dalip Puri as vice president
- Meet Group appoints Bedi A. Singh to board
- Bon-Ton Stores elects William Tracy to board
- L.B. Foster appoints James P. Maloney as CFO
More inside POST
Big Lots Q2 income $29.1 million Earnings
Alibaba Q1 profit surges 96 percent Earnings